(Q47635235)

4 February 2018

title

Update on Medication-Overuse Headache and Its Treatment. (English)

1 reference

4 February 2018

1 reference

3

Paolo Martelletti

1 reference

4 February 2018

Maria Adele Giamberardino

series ordinal

1

1 reference

4 February 2018

Dimos-Dimitrios Mitsikostas

series ordinal

2

1 reference

4 February 2018

publication date

1 August 2015

1 reference

4 February 2018

Current treatment options in neurology

published in

1 reference

4 February 2018

volume

17

1 reference

4 February 2018

page(s)

368

1 reference

4 February 2018

issue

8

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.1007/s11940-015-0368-z

exact match

0 references

cites work

Emerging drugs for migraine treatment

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Headache disorders are third cause of disability worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Emerging treatment for chronic migraine and refractory chronic migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Medication-overuse headache: epidemiology, diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Refractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Prevalence of chronic headache with and without medication overuse: associations with socioeconomic position and physical and mental health status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Chronic migraine plus medication overuse headache: two entities or not?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Trends in opioid analgesic use for headaches in US emergency departments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Psychometric properties of the stagnation scale in medication overuse headache patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Chronic migraine with medication overuse: association between disability and quality of life measures, and impact of disease on patients' lives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Contribution of myofascial trigger points to migraine symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Myofascial pain syndromes and their evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Pain thresholds in women with chronic pelvic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Psychiatric comorbidity in patients with chronic daily headache and migraine: a selective overview including personality traits and suicide risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

The International Classification of Headache Disorders, 3rd edition (beta version)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

A classification of chronic pain for ICD-11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Pathophysiology of medication overuse headache--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Reduction in medication-overuse headache after short information. The Akershus study of chronic headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Management of medication-overuse headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Combined effect of common gene variants on response to drug withdrawal therapy in medication overuse headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Preliminary results of a withdrawal and detoxification therapeutic regimen in patients with probable chronic migraine and probable medication overuse headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

A 4-year follow-up of patients with medication-overuse headache previously included in a randomized multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Rates and predictors for relapse in medication overuse headache: a 1-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Chronic daily headache with medication overuse: predictors of outcome 1 year after withdrawal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Refractory headache: one term does not cover all--a statement of the European Headache Federation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Prevention of medication overuse in patients with migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Prednisone as initial treatment of analgesic-induced daily headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Rehabilitating chronic migraine complicated by medication overuse headaches: how can we prevent migraine relapse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Prednisolone does not reduce withdrawal headache: a randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

The efficacy of withdrawal therapy in subjects with chronic daily headache and medication overuse following prophylaxis with topiramate and amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Time course of adverse events most commonly associated with topiramate for migraine prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Sodium valproate in migraine without aura and medication overuse headache: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Insights into the mechanism of onabotulinumtoxinA in chronic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

EFNS guideline on the treatment of tension-type headache - report of an EFNS task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Preventive treatment in migraine and the new US guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

Neuromodulation of chronic headaches: position statement from the European Headache Federation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-015-0368-Z

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

21 January 2018

1 reference

12 December 2020

Prednisone vs. placebo in withdrawal therapy following medication overuse headache

1 reference

12 December 2020

Practical management of medication-overuse headache.

1 reference

12 December 2020

Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: A comparison of two consecutive treatment methods in an open-label design

1 reference

12 December 2020

The therapeutic armamentarium in migraine is quite elderly

1 reference

12 December 2020

Effectiveness of the telephonic-case-management for treatment of headache. A pilot study.

1 reference

12 December 2020

The International Classification of Headache Disorders: 2nd edition

1 reference

12 December 2020

Cervical 10 kHz spinal cord stimulation in the management of chronic, medically refractory migraine: A prospective, open-label, exploratory study.

1 reference

12 December 2020

Correlation between Migraine Severity and Cholesterol Levels.

1 reference

12 December 2020

Medication overuse headache: rates and predictors for relapse in a 4-year prospective study

1 reference

12 December 2020

Neurostimulation methods in the treatment of chronic pain

1 reference

12 December 2020

Medication Overuse Headache

1 reference

12 December 2020

Disability in chronic migraine with medication overuse: treatment effects through 5 years

1 reference

12 December 2020

Long term headache duration is a factor predicting nonresponse to detoxification and advice in medication overuse headache

1 reference

12 December 2020

Disability in Chronic Migraine Patients With Medication Overuse: Treatment Effects at 1-Year Follow-up

1 reference

12 December 2020

Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society

1 reference

12 December 2020

Chronic daily headache with medication overuse: a randomized follow-up by neurologist or PCP

1 reference

12 December 2020

10.1007/S11940-015-0368-Z

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

26139553

1 reference

4 February 2018